|
|
OsteoporosisThe UK NSC policy on Osteoporosis screening in women after the menopausePolicy
What is screening?Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition. It is important to ensure that the benefits and downsides of screening have been properly thought through. The UK National Screening Committee (UK NSC) is responsible for reviewing screening policies every 3 years and making recommendations to ministers in the 4 UK countries about whether to not a screening programme for a certain condition should be set up. » Find out more about screening, the role of the UK NSC or the policy review process More about OsteoporosisOsteoporosis is a condition that affects the bones, causing them to become thin and weak. Approximately three million people in the UK have osteoporosis, and there are over 230,000 fractures every year as a result. Osteoporosis happens more commonly in old age when the body becomes less able to replace worn-out bone. Special cells within the bones, called living bone cells, are no longer able to break down old bone and renew it with healthy, dense new bone. » Read more about osteoporosis on NHS Choices Policy stakeholders • Age UK The stakeholder groups will be involved when the policy is next reviewed. If you think your organisation should be added, please contact us. More about the policy review process, including the role of stakeholders, can be found in the guide to Engaging with the UK NSC's policy review process. Related documentsMore optionsGo to top |
![]() | ||||||||||||||||